DC

DNE Capital Management

North America, Arizona, United States, Scottsdale

Description

DNE Capital Management is an investment firm.

Investor Profile

DNE Capital Management has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Genetics, Life Science.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DNE Capital Management frequently co-invest with?

New Frontier Health
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
Linden Asset
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Jinyi Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Innolink Fund
Asia, Beijing, China, Haidian
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Chimera Investment
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
Keyuan Industry Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by DNE Capital Management?

Abogen Biosciences

Suzhou, Jiangsu, China

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

BiotechnologyGeneticsLife Science
Series CNov 29, 2021
Amount Raised: $300,000,000